Stockscreener 앱 받기
120.24
5.03%
5.76
Glaukos Corporation 주식(GKOS)의 최신 뉴스
EPS Watch: What hedge funds are buying ProShares Trust ProShares UltraShort FTSE China 50Share Buyback & Trade Opportunity Analysis - baoquankhu1.vn
Glaukos Sees Revenue Surge as Analysts Raise Price Targets - StocksToTrade
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Glaukos (GKOS) - The Globe and Mail
How Glaukos’ Reaffirmed 2026 Sales Guidance and iDose TR Momentum Will Impact Glaukos (GKOS) Investors - simplywall.st
Glaukos (NYSE:GKOS) Trading 7.8% HigherHere's What Happened - MarketBeat
Glaukos Surges with Strong Year-End Financials and Optimistic Future Outlook - StocksToTrade
Glaukos Reports Preliminary Q4 and 2025 Results, Reaffirms 2026 Revenue Guidance - VisionMonday.com
Needham Reiterates Buy Rating for Glaukos (GKOS) | GKOS Stock Ne - GuruFocus
Glaukos stock falls despite strong Q4 revenue beat, UBS reiterates Buy By Investing.com - Investing.com Australia
Glaukos (NYSE:GKOS) Shares Gap DownHere's What Happened - MarketBeat
Glaukos stock falls despite strong Q4 revenue beat, UBS reiterates Buy - Investing.com Canada
Glaukos (GKOS) Shares Drop Significantly in Recent Trading - GuruFocus
Glaukos Corp (GKOS) Projects FY25 Sales of $507 Million, Shares Drop 12.1% - Intellectia AI
Glaukos stock holds Overweight rating at Piper Sandler on strong Q4 results - Investing.com Australia
Glaukos' (GKOS) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat
Glaukos stock holds Overweight rating at Piper Sandler on strong Q4 results By Investing.com - Investing.com Nigeria
Glaukos, Trip.com Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
S&P 500 Futures Fall in Premarket Trading; Glaukos, Fortinet Lag - Barron's
What 14 Analyst Ratings Have To Say About Glaukos - Benzinga
Breakout Move: What is the long term forecast for Glaukos Corporation stockPortfolio Performance Report & Consistent Profit Trade Alerts - baoquankhu1.vn
Glaukos reports 36% revenue growth in Q4, reaffirms 2026 guidance By Investing.com - Investing.com Nigeria
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2 - PharmiWeb.com
Glimpse Into Glaukos (GKOS): Financial Standing and Cash Reserves - GuruFocus
Glaukos Reports Strong Preliminary Q4 and 2025 Sales Growth - TipRanks
Glaukos (GKOS) Reaffirms 2026 Revenue Forecast at $600M-$620M - GuruFocus
Glaukos stock falls after preliminary Q4 sales beat estimates By Investing.com - Investing.com South Africa
Glaukos Reaffirms 2026 Revenue Guidance of $600 Million to $620 Million, Shares Fall After Hours - marketscreener.com
Glaukos stock falls after preliminary Q4 sales beat estimates - Investing.com UK
Glaukos announces preliminary, unaudited fourth quarter results - marketscreener.com
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance - Business Wire
Hedge Fund Moves: What momentum indicators show for Glaukos Corporation stock2025 Short Interest & Reliable Volume Spike Alerts - Bộ Nội Vụ
Risk Report: Is Glaukos Corporation stock a safe haven assetTrade Ideas & Safe Capital Growth Stock Tips - Bộ Nội Vụ
Gainers Report: Will Glaukos Corporation stock gain from government policiesTrade Volume Summary & Low Drawdown Investment Strategies - Bộ Nội Vụ
Glaukos Corporation (GKOS) Stock Analysis: Unpacking a 38.10% Revenue Growth with Potential 13.86% Upside - DirectorsTalk Interviews
Understanding Momentum Shifts in (GKOS) - Stock Traders Daily
Can Glaukos Corporation stock deliver sustainable ROEWeekly Profit Recap & High Conviction Buy Zone Picks - Улправда
Why Glaukos Corporation stock is listed among top recommendations - ulpravda.ru
How Glaukos Corporation stock compares to industry benchmarksMarket Movement Recap & Daily Profit Maximizing Tips - Улправда
Why Glaukos Corporation stock could be top winnerEntry Point & Reliable Intraday Trade Alerts - ulpravda.ru
Will Glaukos Corporation stock deliver consistent dividendsJuly 2025 PreEarnings & Free Real-Time Market Sentiment Alerts - Улправда
Issuer of GKOS (GKOS) common stock files Rule 144 sale notice - Stock Titan
Technical Analysis: Is Glaukos Corporation stock supported by strong fundamentalsJuly 2025 Drop Watch & AI Powered Buy and Sell Recommendations - Улправда
Is Glaukos Corporation stock supported by strong fundamentalsMarket Performance Report & Weekly Top Performers Watchlists - ulpravda.ru
Can Glaukos Corporation stock resist market sell offsTrend Reversal & Safe Entry Zone Tips - ulpravda.ru
Analysis Recap: Why Glaukos Corporation stock is listed among top recommendationsAnalyst Upgrade & Safe Swing Trade Setup Alerts - Улправда
Market Review: How geopolitical risks impact Glaukos Corporation (6GJ) stock2025 Price Momentum & Daily Chart Pattern Signal Reports - ulpravda.ru
Glaukos (GKOS) director Hoffmeister granted 753 restricted stock units - Stock Titan
Glaukos (GKOS) director Marc Stapley receives 727 restricted stock units - Stock Titan
Glaukos (GKOS) director Kliman reports 623 restricted stock units granted - Stock Titan
Is Glaukos Corporation stock positioned for digital transformationMarket Sentiment Indicators & Double Digit Returns - ulpravda.ru
Published on: 2026-01-07 21:02:26 - ulpravda.ru
Glaukos Corporation's (NYSE:GKOS) Shift From Loss To Profit - simplywall.st
FDA accepts Glaukos application for Epioxa for keratoconus - MSN
Glaukos approved for $14M Alabama tax credit - Lagniappe Daily
Block Trades: How geopolitical risks impact Glaukos Corporation 6GJ stockWeekly Profit Report & Capital Efficient Trade Techniques - moha.gov.vn
Glaukos Corporation (GKOS) Stock Analysis: A Promising 13.99% Upside in the Medical Devices Sector - DirectorsTalk Interviews
Allspring Global Investments Holdings LLC Sells 13,317 Shares of Glaukos Corporation $GKOS - MarketBeat
Glaukos Corporation (NYSE:GKOS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
0.42%
1.96%
자본화:
|
볼륨(24시간):